Jason M. D. Kalapothakis
University of Edinburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jason M. D. Kalapothakis.
Analytical Chemistry | 2008
Bryan J. McCullough; Jason M. D. Kalapothakis; Hayden Eastwood; Paul Kemper; Derek Macmillan; Karen Taylor; Julia R. Dorin; Perdita E. Barran
We describe here a new ion mobility capable mass spectrometer which comprises a drift cell for mobility separation and a quadrapole time of flight mass spectrometer for mass analysis--the MoQTOF. A commercial QToF instrument (Micromass UK Ltd., Manchester, UK) has been modified by the inclusion of an additional chamber containing a drift cell and ancillary ion optics. The drift cell is 5.1 cm long made from a copper block and is mounted from a top hat flange in a chamber situated post source optics and prior to the quadapole analyzer. Details of this instrument are provided along with information about how it can be used to acquire mobilities of ions along with their mass to charge ratios. The MoQTOF is used to examine conformations of a series of antimicrobial peptides based on a beta-defensin template. In vivo, these cationic cystine-rich amphiphilic peptides are conformationally restrained by three or more disulfide bridges, although recent findings by several groups have cast doubt on the importance of canonical disulfide pairing to antimicrobial activities. By synthesizing a panel of variants to Defb14 (the murine orthologue of HBD3), we exploit ion mobility to distinguish conformational differences which arise due to disulfide formation and to the hydrophobicity of the peptide sequence. Our gas-phase results are interpreted in terms of the antimicrobial and chemotacic properties of beta-defensins, and this mass spectrometry based approach to discern structure may have a role in future design of novel antibiotics.
Analyst | 2015
Ashley S. Phillips; Alexandre F. Gomes; Jason M. D. Kalapothakis; Jay Gillam; Jonas Gasparavicius; Fabio C. Gozzo; Tilo Kunath; Cait E. MacPhee; Perdita E. Barran
The aggregation and deposition of α-synuclein in Lewy bodies is associated with the progression of Parkinsons disease. Here, Mass Spectrometry (MS) is used in combination with Ion Mobility (IM), chemical crosslinking and Electron Capture Dissociation (ECD) to probe transient structural elements of α-synuclein and its oligomers. Each of these reveals different aspects of the conformational heterogeneity of this 14 kDa protein. IM-MS analysis indicates that this protein is highly disordered, presenting in positive ionisation mode with a charge state range of 5 ≤z≤ 21 for the monomer, along with a collision cross section range of ∼1600 Å(2). Chemical crosslinking applied in conjunction with IM-MS captures solution phase conformational families enabling comparison with those exhibited in the gas phase. Crosslinking IM-MS identifies 3 distinct conformational families, Compact (∼1200 Å(2)), Extended (∼1500 Å(2)) and Unfolded (∼2350 Å(2)) which correlate with those observed in solution. ECD-Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry (ECD-FT-ICR MS) highlights the effect of pH on α-synuclein structure, identifying the conformational flexibility of the N and C termini as well as providing evidence for structure in the core and at times the C terminus. A hypothesis is proposed for the variability displayed in the structural rearrangement of α-synuclein following changes in solution pH. Following a 120 h aggregation time course, we observe an increase in the ratio of dimer to monomer, but no gross conformational changes in either, beyond the significant variations that are observed day-to-day from this conformationally dynamic protein.
Antimicrobial Agents and Chemotherapy | 2010
Natalie L. Reynolds; Martin De Cecco; Karen Taylor; Chloe Stanton; Fiona Kilanowski; Jason M. D. Kalapothakis; Emily S. Seo; Dušan Uhrín; Dominic J. Campopiano; John R. W. Govan; Derek Macmillan; Perdita E. Barran; Julia R. Dorin
ABSTRACT β-Defensins are known to be both antimicrobial and able to chemoattract various immune cells. Although the sequences of paralogous genes are not highly conserved, the core defensin structure is retained. Defb14-1CV has bactericidal activity similar to that of its parent peptide (murine β-defensin Defb14) despite all but one of the canonical six cysteines being replaced with alanines. The 23-amino-acid N-terminal half of Defb14-1CV is a potent antimicrobial while the C-terminal half is not. Here, we use a library of peptide derivatives to demonstrate that the antimicrobial activity can be localized to a particular region. Overlapping fragments of the N-terminal region were tested for their ability to kill Gram-positive and Gram-negative bacteria. We demonstrate that the most N-terminal fragments (amino acids 1 to 10 and 6 to 17) are potent antimicrobials against Gram-negative bacteria whereas fragments based on sequence more C terminal than amino acid 13 have very poor activity against both Gram-positive and -negative types. We further test a series of N-terminal deletion peptides in both their monomeric and dimeric forms. We find that bactericidal activity is lost against both Gram types as the deletion region increases, with the point at which this occurs varying between bacterial strains. The dimeric form of the peptides is more resistant to the peptide deletions, but this is not due just to increased charge. Our results indicate that the primary sequence, together with structure, is essential in the bactericidal action of this β-defensin derivative peptide and importantly identifies a short fragment from the peptide that is a potent bactericide.
Chemical Communications | 2014
Jason M. D. Kalapothakis; Yana Berezovskaya; Cleidiane G. Zampronio; Peter A. Faull; Perdita E. Barran; Helen J. Cooper
The helix-forming character of a model decapeptide, L4PL4K, is determined in the absence of solvent using ion mobility mass spectrometry, electron capture dissociation and molecular mechanics simulations. Unusual ECD fragmentation patterns dominated by b ions are attributed to helix formation upon electron capture and as a signature of conformational dynamics.
Biophysical Journal | 2015
Jason M. D. Kalapothakis; Ryan J. Morris; Juraj Szavits-Nossan; Kym Eden; Sam Covill; Sean Tabor; Jay Gillam; Perdita E. Barran; Rosalind J. Allen; Cait E. MacPhee
The ability to control the morphologies of biomolecular aggregates is a central objective in the study of self-assembly processes. The development of predictive models offers the surest route for gaining such control. Under the right conditions, proteins will self-assemble into fibers that may rearrange themselves even further to form diverse structures, including the formation of closed loops. In this study, chicken egg white ovalbumin is used as a model for the study of fibril loops. By monitoring the kinetics of self-assembly, we demonstrate that loop formation is a consequence of end-to-end association between protein fibrils. A model of fibril formation kinetics, including end-joining, is developed and solved, showing that end-joining has a distinct effect on the growth of fibrillar mass density (which can be measured experimentally), establishing a link between self-assembly kinetics and the underlying growth mechanism. These results will enable experimentalists to infer fibrillar morphologies from an appropriate analysis of self-assembly kinetic data.
Analytical Chemistry | 2014
Rebecca Beveridge; Sam Covill; Kamila J. Pacholarz; Jason M. D. Kalapothakis; Cait E. MacPhee; Perdita E. Barran
International Journal of Mass Spectrometry | 2009
Peter A. Faull; Karoliina E. Korkeila; Jason M. D. Kalapothakis; Andrew Gray; Bryan J. McCullough; Perdita E. Barran
Analytical Chemistry | 2012
Ewa Jurneczko; Jason M. D. Kalapothakis; Iain D. G. Campuzano; Michael Morris; Perdita E. Barran
Analyst | 2011
Hannah V. Florance; Andrew P. Stopford; Jason M. D. Kalapothakis; Bryan J. McCullough; Andrew Bretherick; Perdita E. Barran
Angewandte Chemie | 2010
Harriet L. Cole; Jason M. D. Kalapothakis; Guy Bennett; Perdita E. Barran; Cait E. MacPhee